InvestorsHub Logo
Followers 14
Posts 453
Boards Moderated 0
Alias Born 05/28/2015

Re: tradeologist post# 2552

Sunday, 11/22/2015 6:46:37 PM

Sunday, November 22, 2015 6:46:37 PM

Post# of 19485
Although I haven't done much research on this ticker yet as you probably know the company can only start making real money (besides milestone payments which I haven't looked into) after the oke of phase 3 by the FDA. Phase 3 is the most costly stage of all. The company will have revenues of royalties from the drug manufacturer, however the financing for the comp will take place long before the oke (= phase 3).

Biotech companies with their R&D are true cash burners. These scientists have hefty salaries. Most biotech comps have alliances again I haven't dd so I don't know that about GOVX. However because a lot of dilution is involved in the pps I would think not. So when the comp starts to earn they don't have to share it with other alliances members. Besides this way of financing is not uncommon in the biotech sector.

Their technology seems to have a high succes rate and barely any side effects. Their technology is capable of tracing, marking and eliminating virusses even when they try to hide in a healthy body cell. This technology seems to be applyable to more and more viral diseases. The sweet thing with one of their Ebola vaccins is they can use it to prevent people from getting the disease in the first place. In other words you don't have to swallow a medicine for the rest of your life (with on the long run all kinds of disturbing side effects for your health).

Investment wise maybe a little early to invest in and for sure a high risk investment as all pennies are at the OTC but if the comp survives this ticker is a gem. We are not just talking about orphan drugs here.

Charlie Sheen has HIV inhibitors which he needs to use for the rest of his life. These medicine only take away the symptoms not the virus, GOVX vaccin does. All IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GOVX News